3Immunophenotype and DNA cell content in multiple myeloma
- 1 December 1995
- journal article
- Published by Elsevier in Bailliere's Clinical Haematology
- Vol. 8 (4), 735-759
- https://doi.org/10.1016/s0950-3536(05)80257-4
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Primary plasma cell leukaemiaBritish Journal of Haematology, 1994
- Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathologyCytometry, 1993
- The biological and clinical significance of the KI‐67 growth fraction in multiple myelomaHematological Oncology, 1992
- Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40Science, 1991
- Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric studyBritish Journal of Cancer, 1990
- High serum IL‐2 levels are predictive of prolonged survival in multiple myelomaBritish Journal of Haematology, 1990
- The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosisBlood, 1985
- Prognostic implications of tumor cell DNA and RNA content in multiple myelomaBlood, 1985
- CALLA-positive myeloma: an aggressive subtype with poor survivalBlood, 1985
- Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma: clinical implicationsBlood, 1982